Yolanda Augustin
St George's, University of London
12 Papers
5 Citations
Yolanda Augustin is an academic researcher from St George's, University of London. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 9 publications.
Chat about Author
Papers
Host genetic factors determining COVID-19 susceptibility and severity.
Thirumalaisamy P. Velavan,Srinivas Reddy Pallerla,Jule Ruter,Yolanda Augustin,Peter G. Kremsner,Sanjeev Krishna,Christian Meyer +6 more
TL;DR: In this article, the authors summarize research on COVID-19 host genetics and compile genetic variants associated with susceptibility to COVID19 and disease severity and discuss candidate genes that should be investigated further to understand such associations and provide insights relevant to pathogenesis, risk classification, therapy response, precision medicine and drug repurposing.
190
Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing.
TL;DR: Artemisinins have an excellent safety and tolerability profile as well as being affordable for deployment in Low and Middle Class Income Countries at around USD1 per daily dose.
73
Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections
Henry M. Staines,Daniela E. Kirwan,David J Clark,Emily R. Adams,Yolanda Augustin,Rachel L Byrne,Michael Cocozza,Ana I Cubas-Atienza,Luis E. Cuevas,Martina Cusinato,Benedict M O Davies,Mark M. Davis,Paul A. Davis,Annelyse Duvoix,Nicholas M Eckersley,Daniel M. Forton,Alice J. Fraser,Gala Garrod,Linda Hadcocks,Qinxue Hu,Michael H. Johnson,Grant A Kay,Kesja Klekotko,Zawditu Lewis,Josephine Mensah-Kane,Stefanie Menzies,Irene M. Monahan,Catherine M. Moore,Gerhard Nebe-von-Caron,Sophie I Owen,Chris Sainter,Amadou A. Sall,James Schouten,Christopher T Williams,John T. Wilkins,Kevin Woolston,Joseph R Fitchett,Sanjeev Krishna,Tim Planche +38 more
TL;DR: Dynamics of seroconversion to SARS-CoV-2 infections detected by IgG ELISA in 177 individuals diagnosed by RT-PCR are reported and higher antibody responses are associated with symptomatic disease, older age, ethnicity, increased co-morbidity and higher inflammatory markers such as C Reactive Protein.
Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration
Emily R. Adams,Yolanda Augustin,Rachel L Byrne,David J Clark,Michael Cocozza,Ana I Cubas-Atienzar,Luis E. Cuevas,Martina Cusinato,Benedict M O Davies,Mark S. Davies,Paul Davies,Annelyse Duvoix,Nicholas M Eckersley,Thomas Edwards,Tom Fletcher,Alice J. Fraser,Gala Garrod,Linda Hadcocks,Qinxue Hu,Michael H. Johnson,Grant A Kay,Katherin Keymer,Daniela E. Kirwan,Kesja Klekotko,Zawditu Lewis,Jenifer C. Mason,Josie Mensah-Kane,Stefanie Menzies,Irene M. Monahan,Catherine M. Moore,Gerhard Nebe-von-Caron,Sophie I Owen,Tim Planche,Chris Sainter,James Schouten,Henry M. Staines,Lance Turtle,Lance Turtle,Christopher T Williams,John T. Wilkins,Kevin Woolston,Amadou A. Sall,Joseph R Fitchett,Sanjeev Krishna +43 more
TL;DR: This is the first in a series of Mologic products for CO VID-19, which will be deployed for COVID-19 diagnosis, contact tracing and sero-epidemiological studies to estimate disease burden and transmission with a focus on ensuring access, affordability, and availability to lowest resource settings.